Lennart Holm

A Genome-Wide Association Study Confirms VKORC1, CYP2C9, and CYP4F2 as Principal Genetic Determinants of Warfarin Dose

Nicole Soranzo, Panos Deloukas, Fumihiko Takeuchi, 2009, PLoS genetics.

[Unclear on dose adjustment in renal impairment].

Lennart Holm, Lennart Holm, Charlotte Asker-Hagelberg, 2013, Lakartidningen.

The largest prospective warfarin-treated cohort supports genetic forecasting.

Panos Deloukas, Niclas Eriksson, Mia Wadelius, 2009, Blood.